JW Kim CEO, Managing Partner
Prior to founding QUAD, JW was with Allianz Global Investors since 2004 as a fund manager and Head of Equities. His track record shows consistent top quartile performance every year from 2006 to 2010. JW started his career at KPMG New York as an accountant after getting his M.B.A. from University of Illinois. JW holds a B.S. in Architectural Engineering and B.A. in Business Administration from Yonsei University and is also a CFA and CAIA.
HS Hwang CEO, Managing Partner
Prior to founding QUAD, HS was a senior fund manager at Corevest Capital in Singapore managing Korea long-short equity portfolios. HS has over 19 years of experience in the equity business. HS brings a wealth of knowledge to our team with extensive experience in the pharmaceuticals and biotechnology sectors. He was ranked as number one pharmaceuticals analyst during his previous career at Woori I&S. HS graduated from Seoul National University with a B.S./ M.S. in Chemistry.
SK Han CIO, Portfolio Manager
SK joined QUAD in January 2015 as CIO. Prior to joining Quad he headed research at Cosmo Asset Management in Korea.
He had also worked at Corevest Capital (Singapore) managing a Pan-Asia long-short fund as a senior fund manager and Mirae Asset Global Investment (Hong Kong) wearing two hats as regional portfolio manager and deputy head of research of their global research division.
SK graduated from Seoul National University with a B.S. in Chemistry and holds a MBA from the Haas School of Business at UC Berkeley.
YH Jung Portfolio Manager
YH started his career at Samsung Securities as an analyst covering the IT sector. He joined Allianz Global Investors in 2005 and worked with JW. YH was ranked as number one performing manager and gained recognition as a mid-small cap specialist managing the largest mid-small cap fund in Korea. YH holds a B.A. in Economics from Seoul National University and is a CFA.
Youngtae Hong Portfolio Manager
Youngtae began his career in 2004 as a research scientist at ViroMed, where he has experienced clinical studies for the development of gene-based biopharmaceuticals. Before joining QUAD, he worked as head of business development at ViroMed. He received his B.S. in Microbiology and M.S. and Ph.D. in Genetic Engineering from Seoul National University.
Jonathan Hsu Portfolio Manager
Prior to QUAD, Jonathan led China Healthcare research at China Merchants Securities (HK) where he was ranked the No.1 Stock Picker in the HK/ China Healthcare Industry by Thomson Reuters StarMine in 2014. He had also worked as the senior analyst covering China Healthcare at Macquarie (HK), an investment analyst at DKR Oasis Fund, and a technology analyst at Deutsche Bank. Before starting his investment career at Lehman Brothers in 2001, Jonathan worked as a research associate at Bio-Synthesis in the U.S. where he developed genotyping kits targeting human leukocyte antigens. Jonathan graduated from UC Berkeley with a B.A. in Molecular and Cell Biology and holds an MBA degree from Georgetown University.
Jibeom Kim Venture Capitalist
Jibeom began his career in 2013 at Kiwoom Securities, where he was in charge of IPO work for the corporate finance team. Prior to joining QUAD, he was part of Principal Investment team at Hanwha Investment & Securities, responsible for investments into private companies and mezzanine products. Jibeom holds a Bachelor's degree in Business Administration from Yonsei University.
Younah Roh Venture Capitalist
Prior to joining QUAD, Younah was a Business Development associate manager at DongA ST. She identified and evaluated assets from domestic and global pharmaceutical companies for potential collaboration or licensing-in. She received her B.S. in Biochemistry from University of Wisconsin-Madison and M.S. in Pharmacy from Seoul National University.
Jay (Yoon Jae) Shin Portfolio Manager
Prior to joining QUAD in 2017, Jay (Yoon Jae) Shin led business development and growth hacking efforts at a data analytics start-up based in Palo Alto, CA. Before this role, Jay was a member of investment team at ZAIS Group, a multi-strategy structured credit fund, responsible for analyzing corporate and mortgage related structured credit opportunities. He started his career at Samjong Investment Advisory in Seoul covering global opportunistic investments for Korean institutional clients. Jay spent 18 years abroad, based in a variety of cities around the globe such as New Delhi, Mumbai, Shanghai, San Francisco Bay Area and New York. He received his M.B.A. from the Wharton School at the University of Pennsylvania and Bachelor’s degree in Business Administration from Yonsei University.
Marcello Ahn Portfolio Manager
Marcello began his career as an auditor at KPMG in 2004 and served as an internal auditor at Merrill Lynch Hong Kong. Before joining QUAD, he worked as a research analyst at Nomura Securities covering the Korea IT sector. Marcello holds a B.A. in Education from Seoul National University. He is also a CPA and CFA.
Justin Hur Venture Capitalist
Justin has been in private equity industry for more than 10 years. Prior to joining QUAD, he was CIO at KL&Partners and Managing Director at IMM Private Equity. Before joining IMM Private Equity in 2009, he was a hedge fund manager at Corevest Capital, and also held the role of management consultant at Monitor Group and Arthur D. Little. Justin received his B.A. from Seoul National University and MBA from Columbia Business School.
JD Yang Portfolio Manager
JD has over 12 years of experience as a research analyst covering the heavy industries(shipbuilding & machinery) sectors. His previous firms are Samsung Securities, Macquarie, and Korea I&S. JD was ranked as best small cap analyst in 2007. JD graduated from Korea University with a B.A. in Business Administration and is also a CAIA.
Seokjun Bae Portfolio Manager
Seokjun began his career in 2010 at Woori Investment Securities. He spent 5 years as a research analyst covering leisure and entertainment as well as hybrid chemical sector. Prior to joining QUAD in Jan 2017, he was a portfolio manager at Samsung Asset Management focusing on mid-small cap names. Seokjun holds a B.A. in Sociology and Economics from Korea University.
JM Kim Portfolio Manager
JM has over 14 years’ industrial experience in biotechnology. Prior to joining QUAD, JM was director of R&D at ViroMed, a leading biotechnology company specializing in DNA/protein-based biopharmaceuticals. He earned his B.S., M.S. and Ph.D. in Microbiology from Seoul National University.
Juhyun Choi Venture Capitalist
Juhyun has over 15 years of experience in biotechnology. Before joining QUAD, Juhyun co-founded Bridge Biothepeutocs, a leading NRDO biotechnology company specialized in autoimmune diseases. Prior to that, he was an associate professor in biochemistry at CHA University’s Medical School. Juhyun also worked at SANOFI as Head of Korea R&D handling technology in-licensing, and he began his professional career at LG Life Sciences in 2008. He earned his Ph.D. in Biotechnology from Korea University and holds B.S. and M.S. in Biochemistry from Hanyang University.
Jinsung Kim Portfolio Manager
Jinsung began his career in 2011 at Woori Investment Securities (currently NH Investment Securities). He spent 5 years as a research analyst covering leisure and entertainment as well as small caps. Prior to joining QUAD in Sep 2018, he was a portfolio manager and analyst at Anda Asset Management focusing on consumer and healthcare sectors. Jinsung holds a B.A. in Business from Korea University.
Kwangwook(Paul) Lee Alternative Investment
Kwangwook (Paul) leads QUAD’s alternative investment strategy. Before joining QUAD, he was senior legal counsel at Korea Investment Corporation, Korea’s sovereign wealth fund. He was also an M&A associate at Woori Investment and Securities (now, NH Investment Securities). He is a licensed attorney in Michigan, U.S., and worked as an associate at U.S. law firms. Paul earned his J.D. from Wake Forest University and B.S. in Finance from Kelley School of Business, Indiana University - Bloomington.
Jean Yang Portfolio Manager
Jean was a research associate covering the consumer sector and a WRAP account manager at Samsung Securities. She holds a B.A. in Business Administration from Korea University and M.B.A. from KAIST. Jean is also a CPA, FRM, CAIA and CFA.
Jin Kang Portfolio Manager
Jin has over 5 years of experience in biomedical research. Prior to joining QUAD, he worked at University of New South Wales (“UNSW”) in Australia as an academic researcher, studying a novel gene that impacts lifespan. He was awarded Ph.D. in Physiology and Pharmacology from UNSW and a Bachelor of Medical Science (Honours - First Class) from UNSW/Western Sydney University.
Sunwoo Kim Portfolio Manager
Sunwoo began his career in 2009 with Mirae Asset Securities as a research associate. Prior to joining QUAD in May 2016, he was a portfolio manager focusing on the healthcare sector at Mirae Asset Global Investments. Sunwoo graduated from the University of Auckland with a BCom in Economics and Finance and is also a CFA and FRM.
Kanghon Cho Venture Capitalist
Kanghon began his career in 2004 as a Product Planner at SKTeletech, which manufactured cellular phones and communications equipment under the brand SKY. Prior to joining QUAD in 2017, he was a venture capitalist at Albatross Investment for about 6 years. Kanghon holds a B.A. in Electronic Engineering from Yonsei University and also an MBA from Seoul National University.
Haisung Lee Venture Capitalist
Haisung comes to QUAD with more than 13 years of experience as a global business development and innovative technology scouting personnel within the healthcare sector. He was part of healthcare related new business initiatives at various conglomerates, including SK, LG, and Samsung. Before joining QUAD, Haisung was an Associate Director at Johnson & Johnson, Asia Pacific, leading various innovation efforts. He has expertise in business development of emerging technologies, such as medical diagnostics device & kits, drug delivery systems, targeted multi-functional contrast agents, and also has considerable experience in M&A of precision medicine and digital healthcare companies.

Haisung received his Bachelor’s Degree in Chemistry from Kyung Hee University, Master's Degree in Chemistry from POSTECH and a Ph.D. in Biomedical Engineering from an Interdisciplinary program between Sungkyunkwan University and Samsung Medical Center.
CW Park Portfolio Manager
CW is an experienced finance and accounting professional with over 14 years of experience in equities and accounting. Prior to joining QUAD, CW was with Allianz Global investors since 2007 as a fund manager and SRI investment specialist. His background includes working as a CPA at PriceWaterhouse Coopers and KPMG Korea. CW holds a B.A. in Business Administration from Yonsei University. CW is a CPA, CFA, and CTA.